HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Abstract
We have recently identified conventional B2 cells as atherogenic and B1a cells as atheroprotective in hypercholesterolemic ApoE(-/-) mice. Here, we examined the development of atherosclerosis in BAFF-R deficient ApoE(-/-) mice because B2 cells but not B1a cells are selectively depleted in BAFF-R deficient mice. We fed BAFF-R(-/-) ApoE(-/-) (BaffR.ApoE DKO) and BAFF-R(+/+)ApoE(-/-) (ApoE KO) mice a high fat diet (HFD) for 8-weeks. B2 cells were significantly reduced by 82%, 81%, 94%, 72% in blood, peritoneal fluid, spleen and peripheral lymph nodes respectively; while B1a cells and non-B lymphocytes were unaffected. Aortic atherosclerotic lesions assessed by oil red-O stained-lipid accumulation and CD68+ macrophage accumulation were decreased by 44% and 50% respectively. B cells were absent in atherosclerotic lesions of BaffR.ApoE DKO mice as were IgG1 and IgG2a immunoglobulins produced by B2 cells, despite low but measurable numbers of B2 cells and IgG1 and IgG2a immunoglobulin concentrations in plasma. Plasma IgM and IgM deposits in atherosclerotic lesions were also reduced. BAFF-R deficiency in ApoE(-/-) mice was also associated with a reduced expression of VCAM-1 and fewer macrophages, dendritic cells, CD4+ and CD8+ T cell infiltrates and PCNA+ cells in lesions. The expression of proinflammatory cytokines, TNF-α, IL1-β and proinflammatory chemokine MCP-1 was also reduced. Body weight and plasma cholesterols were unaffected in BaffR.ApoE DKO mice. Our data indicate that B2 cells are important contributors to the development of atherosclerosis and that targeting the BAFF-R to specifically reduce atherogenic B2 cell numbers while preserving atheroprotective B1a cell numbers may be a potential therapeutic strategy to reduce atherosclerosis by potently reducing arterial inflammation.
AuthorsTin Kyaw, Christopher Tay, Hamid Hosseini, Peter Kanellakis, Tahlia Gadowski, Fabeinne MacKay, Peter Tipping, Alex Bobik, Ban-Hock Toh
JournalPloS one (PLoS One) Vol. 7 Issue 1 Pg. e29371 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID22238605 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Apolipoproteins E
  • B-Cell Activation Factor Receptor
  • Ccl2 protein, mouse
  • Chemokine CCL2
  • Cytokines
  • Inflammation Mediators
  • Tnfrsf13c protein, mouse
Topics
  • Animals
  • Apolipoproteins E (genetics, physiology)
  • Arteries (cytology, metabolism, pathology)
  • Arteritis (complications, genetics, pathology, prevention & control)
  • Atherosclerosis (complications, genetics, metabolism, pathology)
  • B-Cell Activation Factor Receptor (genetics, physiology)
  • Chemokine CCL2 (genetics, metabolism)
  • Cytokines (genetics, metabolism)
  • Cytoprotection (genetics)
  • Down-Regulation (physiology)
  • Endothelial Cells (classification, metabolism, pathology, physiology)
  • Gene Expression Regulation
  • Inflammation Mediators (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: